as attached

To, JULY 22, 2026 The General Manager BSE Limited P.J. Towers, Dalal Street, Mumbai -400 001 BSE Scrip: 519242 Subject: Revised Outcome of Board Meeting held on Saturday, July 4, 2026 Reference: Outcome of board meeting filed on 04.07.2026 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”): Dear Sir, With reference to the cap(cid:415)oned subject and our earlier exchange submission dated July 4, 2026, this is to inform you that, the Board of Directors of the Company, at its mee(cid:415)ng held on Saturday, July 4, 2026, commenced at 3:00 p.m. and concluded at 5:40 p.m. at the Registered Office of the Company, have also considered and approved the following agenda which was le(cid:332) to men(cid:415)on in outcome of board mee(cid:415)ng filed earlier: Agenda- To approve the change in the name of the Company from "Sarda Proteins Limited" to such other name as may be approved by the Central Registration Centre (CRC), Ministry of Corporate Affairs, and consequent alteration of the Memorandum of Association and Articles of Association of the Company. You are requested to kindly take the above agenda item on your record over and above other agenda items approved in board meeting dated July 4, 2026. Thanking you, For, Sarda Proteins Limited Mr. Shirish Dhirajlal Savaliya Managing Director, DIN: 08721554